A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age

被引：0

作者：

Lewis, D. ^{[1
]}

Winner, P. ^{[2
]}

Saper, J. ^{[3
]}

Ness, S. ^{[4
]}

Polverejan, E. ^{[5
]}

Kurland, C. ^{[6
]}

Ford, L. ^{[4
]}

Eerdekens, M. ^{[7
]}

机构：

[1] Childrens Hosp Kings Daughters, Eastern Virginia Med Sch, Div Pediat Neurol, Norfolk, VA USA

[2] Palm Beach Headache Ctr, W Palm Beach, FL USA

[3] Michigan Head Pain & Neurol Inst, Ann Arbor, MI USA

[4] Johnson & Johnson Pharmaceut Res & Dev LLC, CNS Pain & Translat Med, Titusville, NJ USA

[5] Johnson & Johnson Pharmaceut Res & Dev LLC, Clin Biostat, Titusville, NJ USA

[6] Johnson & Johnson Pharmaceut Res & Dev LLC, CNS Pain & Mature Prod TA Operat, Titusville, NJ USA

[7] Johnson & Johnson Pharmaceut Res & Dev LLC, CNS Analgesia, Antwerp, Belgium

来源：

HEADACHE | 2008年 / 48卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S8 / S9

页数：2

共 50 条

[31] A double blind, randomized, placebo-controlled, parallel study to determine the efficacy of topiramate in the prophylactic treatment of migraine
Potter, DL
Hart, DE
Calder, CS
Storey, JR
NEUROLOGY, 2000, 54 (07) : A15 - A15
[32] Demonstrating the early onset of response for topiramate during randomized, double-blind, placebo-controlled migraine prevention trials
Diener, HC
Freitag, F
Hulihan, J
Wu, SC
CEPHALALGIA, 2004, 24 (09) : 807 - 808
[33] Efficacy and Safety of Cinnarizine in the Prophylaxis of Migraine in Children: A Double-Blind Placebo-Controlled Randomized Trial
Ashrafi, Mahmoud Reza
Salehi, Soodeh
Malamiri, Reza Azizi
Heidari, Morteza
Hosseini, Seyed Ahmad
Samiei, Mahboubeh
Tavasoli, Ali Reza
Togha, Mansoureh
PEDIATRIC NEUROLOGY, 2014, 51 (04) : 503 - 508
[34] Efficacy of topiramate in the treatment of essential tremor: A randomized, double-blind, placebo-controlled, crossover study
Connor, GS
ANNALS OF NEUROLOGY, 2000, 48 (03) : 486 - 486
[35] Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine With/Without aura in adults: A randomized, placebo-controlled, double-blind, 12-week pilot study
Silberstein, Stephen D.
Hulihan, Joseph
Karim, M. Rezaul
Wu, Shu-Chen
Jordan, Donna
Karvois, Debra
Kamin, Marc
CLINICAL THERAPEUTICS, 2006, 28 (07) : 1002 - 1011
[36] Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab (AMG 334) in migraine prevention: primary results of the STRIVE Trial
Goadsby, P. J.
Reuter, U.
Bonner, J.
Broessner, G.
Hallstrom, Y.
Zhang, F.
Sapra, S.
Picard, H.
Mikol, D.
Lenz, R.
EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 117 - 117
[37] Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention: Primary Results of the STRIVE Trial
Goadsby, Peter
Reuter, Uwe
Bonner, Jo
Broessner, Gregor
Hallstrom, Yngve
Zhang, Feng
Sapra, Sandhya
Picard, Hernan
Mikol, Daniel
Lenz, Robert
NEUROLOGY, 2017, 89 (08) : E104 - E104
[38] Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention: Primary Results of the STRIVE Trial
Goadsby, P. J.
Reuter, U.
Bonner, J.
Broessner, G.
Hallstrom, Y.
Zhang, F.
Sapra, S.
Picard, H.
Mikol, D. D.
Lenz, R. A.
HEADACHE, 2017, 57 : 128 - 129
[39] Efficacy of coenzyme Q10 for the prevention of migraine in women: A randomized, double-blind, placebo-controlled study
Dahri, Monireh
Hashemilar, Mazyar
Asghari-Jafarabadi, Mohammad
Tarighat-Esfanjani, Ali
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2017, 16 : 8 - 14
[40] A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil in Subjects with Erectile Dysfunction
Goldstein, Irwin
McCullough, Andrew R.
Jones, LeRoy A.
Hellstrom, Wayne J.
Bowden, Charles H.
DiDonato, Karen
Trask, Brenda
Day, Wesley W.
JOURNAL OF SEXUAL MEDICINE, 2012, 9 (04): : 1122 - 1133

← 1 2 3 4 5 →